News

BlogsPosts
Press Release
RepliCel Retains Westwicke Partners as Investor Relations Counsel
VANCOUVER, BC – September 4, 2013 – RepliCel Life Sciences Inc. (OTCBB: REPCF) (CNSX: RP),
BlogsPosts
Press Release
RepliCel Announces Closing of Private Placement
VANCOUVER, BC – April 10, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)
BlogsPosts
Press Release
Replicel and Shiseido Complete Collaboration and Technology Transfer Agreement on Technology for Treating Pattern Baldness
VANCOUVER, BC – July 11, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)
BlogsPosts
Press Release
RepliCel and Shiseido Announce Collaboration and Technology Transfer Framework Agreement and Exclusive Geographic Technology License
Tokyo, Japan and Vancouver, Canada – May 29, 2013 – RepliCel Life Sciences Inc. (the
BlogsPosts
Event
Dr. Jerry Shapiro to Present RepliCel Data to European Academy of Dermatology and Venereology in Poland
VANCOUVER, BC – May 23, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)
BlogsPosts
Press Release
RepliCel Announces Closing of Private Placement
VANCOUVER, BC – May 21, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)
BlogsPosts
Event
RepliCel Presents Further Clinical Data and Corporate Update at its Annual General Meeting of Shareholders
VANCOUVER, BC – June 11, 2012 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)
BlogsPosts
Press Release
RepliCel Announces New Tendon Repair Technology Based on its Hair Follicle Cellular Expertise
VANCOUVER, BC – April 30, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)
BlogsPosts
As Seen In
Vancouver Biotech Receives U.S. Patent for Hair Regeneration Technology
By Emma Crawford, Thu Apr 18, 2013 10:53am PST Vancouver biotech RepliCel Life Sciences Inc. (OTCQB:REPCF)(CNSX:RP)
BlogsPosts
Press Release
RepliCel Receives Issue Notification from the United States Patent and Trademark Office Protecting Methods of Preparing Dermal Sheath Cup Cells for its Hair Regeneration Technology
VANCOUVER, BC – April 18, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)
BlogsPosts
Press Release
RepliCel Announces Closing of Private Placement
VANCOUVER, BC – April 10, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)
BlogsPosts
Press Release
RepliCel to Present at the 11th Annual BioPartnering North America Conference
Vancouver Convention Centre, Vancouver, BC, February 24-26th, 2013
BlogsPosts
Press Release
RepliCel Announces Re-Pricing of Warrants
VANCOUVER, BC – February 8, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)
BlogsPosts
Press Release
RepliCel to Meet with German Competent Authority on its RCH-01 Autologous Hair Cell Manufacturing Process
Phase II Dose Ranging Trial Planned for 2013
BlogsPosts
Press Release
RepliCel Completes First Pre-Filing Review with German Competent Authority on its RCH-01 Autologous Hair Cell Manufacturing Pro
Phase II Dose Ranging Trial on its Hair Cell Replication Technology Expected to Commence Mid-2013
BlogsPosts
Press Release
RepliCel’s Common Shares Listed on CNSX
VANCOUVER, BC – October 1, 2012 – RepliCel Life Sciences Inc. (the “Company” or
BlogsPosts
Event
RepliCel’s Chief Medical Officer to Present at 21st European Academy of Dermatology & Venereology Congress
VANCOUVER, BC – September, 26, 2012 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)
BlogsPosts
Event
RepliCel to Present at Rodman and Renshaw Global Investment Conference
VANCOUVER, BC – September 10, 2012 – RepliCel Life Sciences Inc.’s (the “Company” or “RepliCel”)
BlogsPosts
As Seen In
Chief Scientist Dr. Kevin McElwee Interviewed In Barcelona Article at Eldiariomontanes.es
  (English Translation) Injected hair stem cells are emerging as the most effective therapy against baldness

BlogsPosts
As Seen In
Chief Scientist Dr. Kevin McElwee Interviewed In Barcelona Article at Hazteoir.org
(English Translation) HAZTEOIR.ORG 
The website of the active citizen June 22, 2012

DISCLAIMER:
The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, RepliCel Life Sciences Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.

THIRD PARTY CONTENT
Please note that any opinion, estimates or forecasts made by the authors of these statements are theirs alone and do not represent opinions, forecasts or predictions of RepliCel Life Sciences Inc. or its management. RepliCel Life Sciences Inc. does not, by its reference or distribution of these links imply its endorsement of, or concurrence with, such information, conclusions or recommendations.